SynthesisJournal of Crohn's & colitis2018

Primary Non-Response to Tumor Necrosis Factor Antagonists is Associated with Inferior Response to Second-line Biologics in Patients with Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis.

Siddharth Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.